Relating to required labeling of certain products containing or derived from aborted human fetal tissue.

SB 122 requires clear labeling on food, medical, and cosmetic products containing or derived from human fetal tissue obtained from abortions. It defines "fetal tissue products" as items made with, manufactured using, or derived from such tissue, and prohibits their sale without conspicuous labeling. The Texas Health and Human Services Commission must establish label requirements by December 1, 2025. This bill directly affects manufacturers and sellers of these products within Texas, mandating transparency about their ingredients without altering product availability.